Acetylcysteine

Generic Name
Acetylcysteine
Brand Names
Acetadote
Drug Type
Small Molecule
Chemical Formula
C5H9NO3S
CAS Number
616-91-1
Unique Ingredient Identifier
WYQ7N0BPYC
Background

Acetylcysteine is an antioxidant and glutathione inducer indicated for mucolytic therapy and the treatment of acetaminophen overdose. Acetylcysteine has also been studied for a wide variety of off-label indications with mixed results.

Acetylcysteine was granted FDA approval on 14 September 1963.

Indication

Acetylcysteine is indicated for mucolytic therapy and in the management of acetaminophen overdose.

Associated Conditions
Acetaminophen Overdose, Chronic Rhinitis, Corneal Diseases, Corneal ulceration, Crusting Rhinitis, Keratopathy, Rhinitis, Sinusitis, Vasomotor Rhinitis, Acute Rhinitis, Subacute Rhinitis
Associated Therapies
Airway secretion clearance therapy

N-acetylcysteine in Liver Transplantation

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2008-08-18
Last Posted Date
2023-04-28
Lead Sponsor
Ibtesam Hilmi
Target Recruit Count
100
Registration Number
NCT00736541
Locations
🇺🇸

Unversity of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)

First Posted Date
2008-07-29
Last Posted Date
2021-04-12
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
46
Registration Number
NCT00724594
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Modulation of Lung Injury Complicating Lung Resection

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-04-10
Last Posted Date
2020-02-05
Lead Sponsor
Imperial College London
Target Recruit Count
52
Registration Number
NCT00655928
Locations
🇬🇧

Royal Brompton Hospital, London, United Kingdom

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-03-20
Last Posted Date
2015-03-05
Lead Sponsor
Zambon SpA
Target Recruit Count
184
Registration Number
NCT00639496
Locations
🇧🇪

U.Z. Ghent, Gent, Belgium

🇫🇷

Hôpital A. Calmette, Lille Cedex, France

🇩🇪

Klinikum Grosshadern, Munich, Germany

and more 4 locations

N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy

First Posted Date
2008-03-18
Last Posted Date
2022-08-25
Lead Sponsor
Rijnstate Hospital
Target Recruit Count
69
Registration Number
NCT00637624
Locations
🇳🇱

Rijnstate Hospital, Arnhem, Gelderland, Netherlands

Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2007-12-18
Last Posted Date
2019-08-02
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
6
Registration Number
NCT00575419
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

N-Acetylcysteine and Arginine Administration in Diabetic Patients

First Posted Date
2007-12-07
Last Posted Date
2007-12-07
Lead Sponsor
University of Turin, Italy
Target Recruit Count
24
Registration Number
NCT00569465
Locations
🇮🇹

"San Giovanni Battista" Hospital of Turin, Turin, Italy

N-acetylcysteine in Alcohol Dependence

Phase 1
Completed
Conditions
Interventions
First Posted Date
2007-12-05
Last Posted Date
2020-03-18
Lead Sponsor
Minneapolis Veterans Affairs Medical Center
Target Recruit Count
46
Registration Number
NCT00568087
Locations
🇺🇸

Minneapolis VA Medical Center, Minneapolis, Minnesota, United States

Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material

First Posted Date
2007-11-14
Last Posted Date
2015-06-08
Lead Sponsor
University of Edinburgh
Target Recruit Count
90
Registration Number
NCT00558142
Locations
🇬🇧

Clinical Research Facility, Royal Infirmary Edinburgh, Edinburgh, Midlothian, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath